Changeflow GovPing Pharma & Drug Safety KRAS Modulating Compounds
Routine Notice Added Final

KRAS Modulating Compounds

Favicon for changeflow.com USPTO Patent Applications - Organic Chemistry (C07D)
Published
Detected
Email

Summary

USPTO published patent application US20260098049A1 for KRAS modulating compounds useful as KRAS inhibitors. The application covers compounds, methods of making and using them, and pharmaceutical compositions. Filed August 11, 2025, with 19 inventors listed.

What changed

USPTO published patent application US20260098049A1 for KRAS modulating compounds useful as KRAS inhibitors, filed August 11, 2025. The application discloses compounds and pharmaceutical compositions, listing 19 inventors including researchers from the pharmaceutical sciences field.

Pharmaceutical companies and researchers working on RAS-family oncology targets should monitor this application's progression. If granted, the patent would confer exclusive rights to the claimed KRAS modulators and associated methods, potentially affecting freedom-to-operate for competing programs in the targeted therapy space.

What to do next

  1. Monitor patent prosecution progress
  2. Review claims for freedom-to-operate analysis
  3. Assess competitive landscape impact

Archived snapshot

Apr 10, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

KRAS MODULATING COMPOUNDS

Application US20260098049A1 Kind: A1 Apr 09, 2026

Inventors

Eda Y. Canales, Christopher T. Clark, Zhimin Du, Yassin M.A. Elbatrawi, Quinn B. Greven, Tezcan Guney, Darryl Kato, Henok H. Kinfe, Irene N. Kiburu, Scott E. Lazerwith, Thomas C.J. Mies, Christopher J. Swank, Rhiannon Thomas-Tran, Guanghu Tong, William J. Watkins, Wilian Augusto Cortopassi Coelho

Abstract

Provided herein are compounds, and pharmaceutically acceptable salts thereof, useful as KRAS inhibitors, methods of making and using the same (singly or in combination with additional agents), and pharmaceutical compositions thereof.

CPC Classifications

C07D 519/00 A61K 31/553

Filing Date

2025-08-11

Application No.

19296626

View original document →

Get daily alerts for USPTO Patent Applications - Organic Chemistry (C07D)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 9th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
US20260098049A1

Who this affects

Applies to
Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Patent application publication Pharmaceutical compound research
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Legal
Topics
Pharmaceuticals Healthcare

Get alerts for this source

We'll email you when USPTO Patent Applications - Organic Chemistry (C07D) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!